Rhumbline Advisers Medpace Holdings, Inc. Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
A detailed history of Rhumbline Advisers transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 72,739 shares of MEDP stock, worth $25.3 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
72,739
Previous 70,000
3.91%
Holding current value
$25.3 Million
Previous $28.8 Million
15.86%
% of portfolio
0.02%
Previous 0.03%
Shares
29 transactions
Others Institutions Holding MEDP
# of Institutions
617Shares Held
25.1MCall Options Held
42.8KPut Options Held
207K-
Black Rock Inc. New York, NY2.58MShares$899 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.55MShares$887 Million0.02% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT909KShares$317 Million1.51% of portfolio
-
State Street Corp Boston, MA753KShares$262 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA628KShares$219 Million0.02% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $10.8B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...